July 22, 2007 – ev3 Inc. and FoxHollow Technologies, Inc. announced a definitive agreement by which ev3 and FoxHollow ...
July 20, 2007 – Despite forecasts by analysts at Thomson Financial that Boston Scientific Corp. would earn $150 million ...
July 20, 2007 – Oraganogenesis Inc. announced that it has received regulatory approval in Canada and Europe for BioSTAR, a device that incorporates a bioresorbable collagen scaffold used to treat patent foramen ovale (PFO), a hole in the heart that is usually asymptomatic.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Source: Wall Street Journal Online July 20, 2007 - U.S. doctors implanted fewer coronary stents in June than any other ...
July 19, 2007 – Abbott announced that the first patient was enrolled in its XIENCE V SPIRIT WOMEN clinical trial, the ...
July 19, 2007 – AtCor Medical Holdings Ltd., the developer and marketer of the SphygmoCor system, which noninvasively ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 18, 2007 - In a related study of over 25,000 initially healthy women, higher triglyceride levels measured after not fasting is associated with an increased risk for cardiovascular events, but his association was not found for triglyceride levels measured after fasting, according to a study in the July 18 issue of JAMA.
July 18, 2007 - Abiomed Inc. announced that its Impella 2.5 and Impella 5.0 circulatory support technologies, new ...
Cardium Therapeutics and its operating unit, InnerCool Therapies, have released its new CoolBlue surface temperature ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 18, 2007 - Cardium Therapeutics and its operating unit, InnerCool Therapies, have released its new CoolBlue surface ...
July 18, 2007 - An analysis based on computerized simulation models suggests that the lifetime risk of cancer associated ...
July 18, 2008 - Cardium Therapeutics announced that the FDA has given it clearance for fast track designation to its ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 17, 2007 - Cordis Corp. announced the introduction in the European market of the Fire Star Rx (Rapid Exchange) PTCA ...
July 17, 2007 – Premier, a U.S. healthcare group purchasing organization, announced that it has extended its agreement ...
July 17, 2007 - Medtronic Inc. announced launch of Reveal XT, an Insertable Cardiac Monitor that features long-term and continuous monitoring of Atrial Fibrillation (AF), in the European market as it recently received CE (Conformité Européenne) Mark.